In his first post for Cannabiz, editor-at-large Rhys Cohen analyses the findings of the 2019 National Drug Strategy Household Survey to find out more about the 97% of Australians who still source their medical cannabis from the black market.

As of July 2020, there are now more than 50,000 Australians who have at some time been approved to be prescribed a medical cannabis product. And the number of active, current prescribed cannabis patients is around 20,000.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Elementum integer enim neque volutpat ac tincidunt vitae semper quis. Eu lobortis elementum nibh tellus molestie nunc. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Magnis dis parturient montes nascetur ridiculus. Dui id ornare arcu odio ut sem. Nisl nunc mi ipsum faucibus vitae.
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh.
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Rhys Cohen

As well as being editor-at-large at Cannabiz, Rhys is the director of Cannabis Consulting Australia, which provides commercial consulting services to various domestic and international cannabis companies....

Join the Conversation

3 Comments

  1. $745 every six weeks. I’m not well served at all, thank you very much! 😑. I have two chronic health conditions and survive financially on DSP. How is that well served? Where is the danger in a plant that is now helping these companies list on the ASX and export product? This is about money only.

    (Edited under Cannabiz’s comment moderation policy).

  2. Hi Rhys. Thank you, you’re so right. It’s the underprivileged, disadvantaged people that suffer the most. It fully makes me wonder what the demographic of the 20,000 legal prescriptions is like? Imho, when cannabis therapeutics are on the PBS, and companies can set up cannabis clinics with trained doctors and pharmacists, they will soon catch that 170,000 other Australians who use non-prescribed cannabis exclusively for medical purposes.